SR

Srinivasa Rao Medarametla

Active Director Designated Partner DIN 10794729
DIN 10794729 First appointment Sep 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivasa Rao Medarametla

Data last updated:

Srinivasa Rao Medarametla is a Designated Partner at Vaarahi Med Solutions Llp (since 2024).

DIN 10794729
Primary Designation Designated Partner
First Appointment 30 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 Sep 20242024Active

Board colleagues of Srinivasa Rao Medarametla

NameDINCompanyDesignation
Jammula Kondalarao10216600Vaarahi Med Solutions LlpDesignated Partner
Venkateswarlu Guduri10794728Vaarahi Med Solutions LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vaarahi Med Solutions Llp
Premium access

Shareholding and investment profile for Srinivasa Rao Medarametla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Rao Medarametla

Srinivasa Rao Medarametla currently holds 1 directorship: Vaarahi Med Solutions Llp (Designated Partner, since 30 Sep 2024).

Srinivasa Rao Medarametla was first appointed on 30 Sep 2024 as Designated Partner at Vaarahi Med Solutions Llp.

The current boards of Srinivasa Rao Medarametla's companies include Jammula Kondalarao (Vaarahi Med Solutions Llp), Venkateswarlu Guduri (Vaarahi Med Solutions Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available